ads-banner

Wednesday, December 17, 2014

Diuretics privacy and confidentiality drug

Diuretics password
Distinguish two types:
Diuretics water density (secretin, enhance parasympathetic drugs) increases the excretion of water and electrolytes biliary epithelial cells, causing increased secretion of bile leakage.
Diuretics real honey stimulates liver cells increased excretion of bile bile like physiology. Depending on the source, there are:
Diuretics secret animal origin
It's bile salts, bile acids or bile full eliminates pigment and cholesterol.
Preparations: Bilifluine, 0.1g capsules, take 2 capsules before each lunch and dinner.
Diuretics native vegetation density
  Art, artichoke, boldo. Preparations used a combination of medicinal plants
Diuretics bile synthesis
Cyclovalon: 50 mg tablets, drink 6-12 tablets / day
Anethole trithion: 0,0125g form of drug particles / seeds. Every day drink 3-6 seeds.
Indication of the diuretic common bile
Symptomatic treatment of gastrointestinal disorders: abdominal distention, flatulence, belching, nausea
Adjunctive therapies against constipation
Contraindications: biliary obstruction and severe hepatic impairment
Drug information confidential
As these drugs cause gallbladder contraction, muscle relaxation and round Oddi. Password completely get rid of the gallbladder.
Physiologically, this effect depends on pancreatozinin cholecystokinin (CCK - PZ) due to duodenal lipid and peptide secreted from the stomach into the tea n. Almost all the drug information is confidential due to excretion CCK- PZ.
Indication: digestive disorders such as bloating, indigestion, heartburn, nausea Contraindications: biliary stones, with a history of amoeba.
Drugs: Sorbitol powder 5g package. Each packet in phase 1 hairpin Convention, taken before meals.

Magnesium sulfate: drink 2 5g

Tuesday, December 9, 2014

Change Research glomerular filtration rate in patients with primary hypertension

The study of 30 people with hypertension author Huynh Van Minh result 50% of patients with proteinuria appeared with many different levels. The level of average blood pressure of 166 / 97mmHg correlated with urinary albumin concentration was 71.9 mg / 24 h. Study of Chu Minh Ha in 05 years from 2001 to 2005 have 3306 patients hospitalized for hypertension in total 92 103 inpatient percentage of 3.6%. In hypertensive complications from kidney failure percentage is 5.9%.
In 1996 researchers working group, track 1795 hypertensive patients 10 years Buckalew author comments hypertensive renal function decline as rapidly. Rate and the higher the number, the time of progression to end-stage renal failure as quickly. The author also Ridao 2001 for similar results. The authors conclude that hypertension is one of the most important factors for kidney disease prognosis and treatment of hypertension decided to slow the progression of kidney failure.
  The study of 840 patients with hypertension and nephropathy, author Peterson commented hypertension treatment will prevent coils early kidney disease and hypertension. Treatment of hypertension decided to slow the progression of kidney failure. NHANES III study comparing over 15600 patients and MDRD study found that 40% of hypertension among glomerular filtration rate of 90 ml / min / 1,73m2 lower MDRD study. However, the blood pressure 160/100 mmHg on the same two studies: 20% of patients with glomerular filtration rate: 15-30 ml / min / 1,73m2 2 times higher than the glomerular filtration rate in the group of 30 ml / min / 1,73m2. Puttinger H. 2003, see Fraser 2013 hypertensive kidney disease is the main cause of end-stage renal failure. When kidney function is severely impaired control of blood pressure treatment and maintain kidney function very difficult. This study suggests that blood pressure control achieved the goal of helping patients reduce kidney damage as well as block in other target organs. Redon J. 2006 epidemiological study of the incidence of cardiovascular disease in patients with renal impairment. The authors concluded that in patients with hypertension, the prevalence of cardiovascular disease increased in the same direction with the severity of renal impairment. Glomerular filtration rate test to help predict cardiovascular patients with hypertension. The study's authors Pontremoli in Genoa, Italy in 459 diabetic patients with primary hypertension untreated. The research results show that the incidence of kidney damage is 24%, 12% and microalbuminuria was reduced creatinine clearance was 13%. The presence of kidney damage leading to cardiovascular abnormalities 3.3 times higher than people without kidney damage. If there is simultaneous decline in creatinine clearance and urinary albumin, up to 68% of patients with a high risk. In conclusion, the authors suggest that the role of assessment tests glomerular filtration rate and urinary microalbumin test is the simplest and most important to assess target organ damage in patients with primary hypertension.

Thus most of the studies showed decreased glomerular filtration rate with the increase in the number of both systolic blood pressure and diastolic. Glomerular filtration rate seems to decrease faster in people with hypertension systolic than diastolic hypertension. Time as long hypertension, the risk reduction in glomerular filtration rate increases. Glomerular filtration rate decreased faster in the elderly. And when the glomerular filtration rate decreased cardiovascular events also increased. Thus it can be said glomerular filtration rate is an independent risk factor for hypertension, although the decline in glomerular filtration rate due to hypertensive renal injury. Glomerular filtration rate in patients with kidney damage caused by hypertension or hypertension are due to improved blood pressure control achieved if the target figure. Glomerular filtration rate is stable if good treatment of urinary albumin levels.

Glomerular filtration rate change due to hypertension

As a general rule, at the beginning of the change in pressure alter renal function, has brought about the change in structure. By the time the structural change will affect the functionality. And finally when the original structure is broken, the function will decline. Hypertensive nephropathy occurs in the majority of hypertensive patients not treated.
The first stage does not change anything, MLCT slight increase.
Following stages: Signs persistent microalbumin in urine is an early stage of hypertensive renal disease. Glomerular filtration rate in normal.
If untreated patients with microalbuminuria will progress to clinical proteinuria (urinary albumin> 300 mg / mg creatinine or> 300 mg / 24 hours). Once clinical proteinuria, glomerular filtration rate will decrease rapidly, kidney failure will become increasingly clear.
Currently hypertensive renal disease is second leading cause of diabetes causes of end-stage renal disease should hemodialysis, peritoneal dialysis or kidney transplantation cycle in many countries. Compared with end-stage chronic kidney disease due to other causes, patients with chronic end-stage renal failure due to hypertension had more cardiovascular risk factors other than clear and mortality rates are higher. Preventing the progression of kidney damage is one of the main goals when treating patients with hypertension. Hypertension is a motivating factor in kidney damage progresses faster. Research MDRD (Modification of Diet in Renal Disease) in the kidney due to many different reasons to see patients with controlled blood pressure was positively reduced glomerular filtration rate slower than patients with blood pressure was maintained at normal levels. When aggregating data from nine clinical trials evaluating the effects of antihypertensive treatment on kidney function, the authors found that people with chronic kidney disease have uncontrolled blood pressure (> 140/90 mmHg) decreased glomerular filtration rate of 12 ml / min / year, whereas those with chronic kidney disease have high blood pressure is 130/85 mm Hg under control decreased glomerular filtration rate is only about 2 ml / min / year (equivalent to the reduction of physiological).
Change glomerular filtration rate in patients with renal hypertension when autoregulation mechanism in the kidney (renal autoregulation) no longer works. Normal renal autoregulation of renal blood flow and keep the pressure in the glomerular stable when the average blood pressure change in a wide range from 80 to 160 mm Hg. The mechanism of the self-regulate vasomotor reflexes of arterioles to (afferent arteriole): When the average reduction in blood pressure, arteriolar dilation to, whereas the average increase in blood pressure, arteriolar to co back. The feedback mechanism tubules - glomeruli (tubuloglomerular feedback) is the change in tone of arterioles to meet with tubular NaCl concentration away. In addition, the co arterioles go (efferent arteriole) mediated angiotensin II also contributes to maintain the pressure in the glomerular renal perfusion pressure decreased. Chart 1 below shows the relationship between average blood pressure body with glomerular filtration pressure, factors determining the glomerular filtration rate. Street performers self-regulate pressure in the glomeruli of normal, chronic hypertension who have normal kidney function and chronic hypertension associated with chronic kidney disease
In patients with chronic hypertension, due to endothelial dysfunction and structural changes of the renal arterioles, glomerular pressure starts to decrease at a rate higher than 80 mmHg and started to increase at a rate higher than 160 mmHg. If performing the change of pressure in accordance with changes in glomerular average blood pressure on a chart, we can see in people with chronic hypertension phenomenon curve "misses to the right." Particularly in patients with hypertension associated with chronic renal injury, self-conditioning system disorders glomerular arterioles before losing the ability to stretch. In this the pressure in the glomerular changes almost parallel with the average blood pressure.
The consequence of the reduction in glomerular pressure is decreased glomerular filtration rate, expressed as increases in serum creatinine. Increases in serum creatinine particularly common in patients with hypertension associated with chronic kidney disease. In the first phase the reduced glomerular filtration rate nature hemodynamic not reflect the reality of kidney damage and is usually transient. Glomerular filtration rate will be restored and improved if better blood pressure control improves the structure and function in renal arterioles and shifting autoregulation curve of normal position. If high blood pressure continues to increase, the damage increases renal fibrosis. clinical proteinuria appears constant and glomerular filtration rate will decrease rapidly. The higher the blood pressure, glomerular filtration rate decreases more. Finally, renal fibrosis completely lost filtering function and required replacement therapy.

The process of dialysis in glomerular

1. The rate of glomerular filtration: One of the two kidneys filter 180 liters of services, including 99% of services are reabsorbed in the tubules, forming only 1-1.5 liters of urine excreted with a product of decomposition of the body. In normal in 1 minute with 1200 ml of blood flow through the kidneys (containing 650 ml of plasma) by 21% cardiac output, but only 125 ml of plasma is filtered through the glomerular membrane in which Bowman. Thus, 125 ml of plasma is filtered through the glomeruli in 1 minute called glomerular filtration flow (or glomerular filtration rate). The process of glomerular filtration agents have similar mechanisms of metabolism at the capillary hydrostatic pressure instantly. It is a passive mechanism, depends on the pressure difference between inside and outside the circuit.
Pressure Filter (P¬L) really pushes service glomerular filtration membrane, calculated by the formula:
PL = PH - (PK + PB)
Among them:
PH: hydrostatic pressure of glomerular capillaries (normal is 60mmHg),
PK: glue pressure in the glomerular capillaries (normal is 32 mmHg),
P¬B¬: How Bowman pressure (normal is 18 mmHg).
Thus, the glomerular filtration rate depends primarily on three factors: pressure filter, filtering capabilities and areas of glomerular filtration membrane.
2. Mechanisms regulating glomerular filtration rate
There are two mechanisms regulating automatic glomerular filtration rate: Stretch arterioles to: the reduced glomerular filtration rate, decreased levels of sodium, chloride characteristics to macula DENSA plated layer. The decrease in the concentration of ions causes the arteries to relax, increasing blood flow to the glomeruli, glomerular filtration rate increases and vice versa. Regulating co arterioles go backwards when reduced renal blood flow, with less sodium and chloride to the macula DENSA, as glomerular cells secrete renin edge, leading to the formation of angiotensin II minimizing travel arterioles, increases in glomerular pressure and increased glomerular filtration rate.
Methods exploration of glomerular filtration function
Glomerular filtration rate was calculated using the formula:
MLCT (GFR) = Kf. PL = k.s.PL = Ki. (PH - PB - PK).
In that ultrafiltration coefficient Kf = ks (k: the ability of the membrane filter, s: is the membrane area). Pl is the pressure filter, PH: hydrostatic pressure of glomerular capillaries (normal is 60mmHg), PK: glue pressure in the glomerular capillaries (normal is 32 mmHg), P¬B¬: pressure how Bowman (normal is 18 mmHg).
In fact to calculate glomerular filtration rate it based on renal clearance with a reagent. The concept of clearance (Clearance) is Muler, Van Slyke first introduced in 1928 when the study of kidney function by determining the volume of blood is purified from urea. Clearance of a substance is the mass of purified plasma totally out of that substance in a unit of time. Van Slyke was formulated to evaluate glomerular clearance:



C: Clearance reagent (ml / h)
U: reagent concentrations in urine (mg%)
P: reagent concentrations in serum (mg%)
V: The volume (ml / min)
1.73: The surface area of the body at the high 1,70m, 70kg is 1,73m2.
S: surface area of the patient's actual body (m2)
Techniques to measure glomerular filtration rate requires the use of these substances freely filtered through the glomeruli, not protein bound, not being reabsorbed or excreted by the kidney tubules, and the substance is not metabolized by the kidney, as well as to collect blood and urine correctly in the given time. Inulin is a substance commonly used in the laboratory, but because of the difficulty of the technique should not be widely applied in clinical practice. Endogenous creatinine is now widely used in practice because of its simplicity and ability to perform easily, cheaply. However the downside is that the accuracy is not high in some cases severe renal impairment, children, the elderly ... Now to overcome the limitations of endogenous creatinine reagent, the authors recommend the use of substances cystatin C and beta testing is 2 microglobulin support for measurement using endogenous creatinine. However because of technical complexity, high cost, so they need time to be widely applicable.
Creatinine clearance with 24-hour urine flow (Clcre 24) is often chosen as the main criteria in clinical practice to assess glomerular filtration rate. The main disadvantage of this test is creatinine is excreted by the kidney tubules should add in creatinine clearance greater than 24 typically carry MLCT and retention of urine in 24 hours unavoidable errors.
There are four formulas are used to calculate the MLCT:
- Formula estimated by the Cockcroft Gault MLCT
eClcre CG (ml / min) = [(140- age) x weight (kg)] / (72 x creatinine HT) x 0.85 (for women)
- Recipe of the MDRD estimate MLCT
MDRD eGFR (ml / min / 1.73 m2) = 186 x (HT creatinine) -1.154 x (age) -0.203 x (0.742 if female) x (1.210 if black)
- Formula MLCT estimate of Japan has been modified MDRD
MDRD eGFR Japan (ml / min / 1.73 m2) = 194 x (HT creatinine) -1.094 x (age) -0.287 x (0.739 if female)
- Formula estimates of CKD-EPI MLCT
+ Female: If HT creatinine ≤ 0,7mg / dL: eGFR = 144 x (HT creatinine) -0.329 x (0.993) age; If HT creatinine> 0,7mg / dL: eGFR = 144 x (HT creatinine) -1.209 x (0.993), age
+ Men: If HT creatinine ≤ 0,9mg / dL: eGFR = 141 x (HT creatinine) -0.411 x (0.993) age; If HT creatinine> 0,7mg / dL: eGFR = 141 x (HT creatinine) -1.209 x (0.993), age

  Through a comparative study of formulas to estimate creatinine clearance, estimated creatinine clearance (eClcre) is the appropriate formula in practice on the Vietnamese people. In fact, computerized and not only give the results of blood creatinine but an MLCT help clinicians know directly the value of glomerular filtration function. Since it can be diagnosed early cases of kidney failure, timely intervention and reduced the proportion of patients with chronic end-stage renal failure.

Hypertension and renal injury DO hypertension

1. Hypertension
Arterial blood pressure depends on cardiac output () and peripheral resistance (R). In people with normal blood pressure is relatively stable due to the regulatory mechanisms of neural and humoral. Hypertension occurs when increased cardiac output or increased peripheral resistance, or increase both factors on which the regulatory mechanisms of the body is no longer valid.
As defined by the World Health Organization, an adult is called hypertension as blood pressure ≥ 140 mmHg maximum and / or blood pressure ≥ 90 mmHg minimum.
1.1. Complications of hypertension
- Complications artery: The first stage only tone, alone, increased intravascular pressure. Period following injury, fibrosis is common to the heart arteriolar narrowing or blockage causing increased peripheral resistance. At this stage, there may be more atherosclerotic plaques. The collaboration between hypertension and atherosclerosis promote the development of different and increasingly aggravate the condition.
- Complications retinal artery: 4 Level:
• Level 1: The narrowing of the arteries, hard look.
• Level 2: Hard Arteries cross vein, Gunn sign (+).
• Level 3: Advanced Production and retinal bleeding.
• Level 4: papilledema.
- Heart Complications: High blood pressure causes increased pressure in the left ventricle leads to myocardial hypertrophy, accelerating the progression of coronary atherosclerosis. The combination of increased demand and decreased oxygen supply to the heart muscle causes myocardial ischemia leading to high rates of myocardial infarction, stroke, arrhythmia and heart failure. The cardiac complications in hypertension: reduction of left ventricular function; left ventricular hypertrophy; coronary artery disease; myocardial infarction; congestive heart failure.
- Complications brain: Include expression transient ischemic, hypertensive encephalopathy, stroke and cerebral infarction include cerebral hemorrhage, meningitis is fatal and serious sequelae.
- Renal Complications: Exercise is the target organ complications of hypertension. Clinically, in a long time, patients do not have symptoms or only subtle symptoms until it has physical damage, kidney failure to appear, but no signs of aggressive
1.2. The situation of hypertension in some countries in the world
The prevalence of hypertension in developed countries are quite high: in Italy is 38%, Sweden 38%, UK 42%, Spain 47%, Finland 49%, Germany 55%, Switzerland 32%. In the United States government as a national program to prevent hypertension should be controlled now at 28%, although still quite high. Asian countries as well as countries in the region, the rate of hypertension was lower in Europe but also high: 36% of India, Nepal 20%, Singapore 26%, China 27%, Malaysia 24 %, Pakistan 23%, 29% of Hong Kong, Sri Lanka 20%, Korea 34%, Japan 45%. In Africa Research in Zambia in 2011 was 34.8% rate of hypertension [69]. In the US, despite a national program from the 70s of the 20th century, but the rate control blood pressure goal (<140/90 mmHg) was only 29%. In Canada the rate is 17%, and Europe at around 10%. In Canada in 1986 - 1992, studied 2551 people from 20-79 years of age, the rate of hypertension 21.3% of which 65.7% were treated, 14.7% were treated intermittently, 19 , 5% of untreated (13.7% of them have no idea hypertension). A study in the US in 1999 - 2000 persons in 1565, the rate of hypertension was 28.7%. Research shows that over 40 million Americans have high blood pressure is not treated. In China analysis of 13 studies in 1998 on a 13,500 adults aged 35-59: results showed that 24% of hypertension in 42% recognize that condition, 31.1% were treated, 6% were control of blood pressure.
1.3. The situation of hypertension in Vietnam
1960, according to a survey of Dang Van Chung, hypertension rate in Vietnam is 2-3%. In 1982, according to a survey of Khue Pham et al, the rate of hypertension in general is 1.95% and the proportion of people over 60 years of hypertension was 9.2%. By 1992, according to the epidemiological investigation of Tran Do Trinh et al, sampling over 36,000 people in eight ecological regions, the rate of hypertension in Vietnam has increased by 11.7%. Following that investigation, 1999 Pham Gia Khai et al, the rate of hypertension in Hanoi increase is 16.05%. The most recent survey (2008) of the Institute of Cardiology in the country, the rate of hypertension in our country is 25.1% among those aged 25 years or older. In 1992, Trinh Tran Do surveyed 1716 people with hypertension are unaware 67.5% patients, 15% said the disease but no treatment, 13.5% of treatment but irregular and improper, only 4 % is the right treatment. In 2002, Pham Gia Khai et al 5012 survey of people aged 25 years and older in four provinces in northern Vietnam as a result of 23% correctly identified the risk of hypertension. In 818 people diagnosed with hypertension, only 94 people are taking blood pressure and the rate is 19.1% better control.
2.Ton kidney damage due to hypertension
The initial lesion is functional lesions occur in a very long time, reversible if treated, only to later stages, fibrosis developed new lesions appear entity of the renal artery and two atrophied kidney fibrosis. In hypertension, decreased renal output but glomerular filtration rate remained help maintain kidney function, but in the long term damage and progressive end-stage renal failure.
Chronic kidney disease as defined by the American Nephrology Association 2012 [88] is the status of kidney damage associated with prolonged expression signs histopathological lesions, signs of prolonged urinary albumin, change the image of kidney , decline in glomerular filtration rate below 60 ml / min.
The stages of chronic kidney disease:
- Phase 1: kidney damage, glomerular filtration rate constant or increases above 90 ml / min.
- Phase 2: kidney damage, glomerular filtration rate reduction of 60-90 ml / min.
- Phase 3: glomerular filtration rate decreased on average 30-59 ml / min.
- Stage 4: severe reduction in glomerular filtration rate 15-29 ml / min
- Stage 5 CKD, reduced glomerular filtration rate below 15 ml / min
2.1. The pathogenesis of kidney damage caused by hypertension
Hypertension, chronic systemic arterial blood vessel damage related to the three mechanisms, such as pressure intravascular flow, changes in vascular endothelial cells, blood vessels restructuring ..
- Flow with high pressure vessels become stiffer. Arterial pulse wave propagation hard work faster, so the pressure vessel ventricular response back from the peripheral arteries earlier. Echo occurs during diastole, increased pressure in the aorta and left ventricle during systole. So, hypertension overloading is due to increased peripheral vascular resistance, due to the hard arteries, reducing the elasticity of the aorta and early feedback from the periphery.
- Changes in vascular endothelial cells by increasing the flow pressure: damage including fibrosis and endothelial thickness, slots between the dilated endothelial cells, endothelial fibrosis beneath. The smooth muscle cells migrate from the middle class to the lower layer of endothelial cells, manifested most clearly in that division of the artery.
- Restructuring angiogenesis and proliferation of vascular smooth muscle cells: the cells under a layer of smooth muscle vascular proliferation, thickening of arterial medial migration and the bottom layer of endothelial cells. The change over to make a thick arteries become stiffer. Disease progression will appear hyaline layer of the arterial wall and fibrosis of arteries, causing narrowing of the arteries. Medial injury continues to evolve, can lead to gangrene and medial aneurysm formation. The small aneurysm occurs, first place in the branch arteries.
2.2. The role of system rennin - angiotensin - aldosterone in relation to blood pressure and kidney function
Renin is an enzyme protein, is released from care organizations access to reduced glomerular extracellular fluid volume. Renin raise the blood pressure effects of low levels return to normal. Renin acts on a plasma protein is essentially globulin angiotensinogen to angiotensin I. The change of NaCl create a signal flow to the kidney marrow cells reach. The decrease in the concentration of Na + will cause increased nNOS and COX-conditioned 2, increased synthesis of prostaglandins and catecholamines PGs, activate the synthesis of cAMP, which was created renin in the kidney marrow cells reach. Increasing NaCl transport reduces ATP levels and increased levels of ADO. ADO will diffuse to reach medulla cells, inactivation of AC and the creation of renin through Gi protein A1 receptor. The increased transport of NaCl in the wound can also increase the phenomenon of secretory of ATP and thus can cause inhibition of the secretion of renin directly through receptor P2Y and activation route Gq-PLC-IP3-Ca2 + access marrow cells in the kidney. AngII circulation can also inactive renin secretion via the AT1 receptor. Renin is the decisive factor AngII number will be generated. It is synthesized, stored and secreted into the systemic circulation by renal artery access granule cells located in the medulla of the arteries in the glomeruli.
There are many types of tests including renin total renin (PRC-plasma rennin Concentration), rennin activity (PRA- plasma retinal activity), rennin inactivated (IRC-inactive renin Concentration). Activated renin (PRA) is a form of rennin activity has a direct effect regulates blood pressure. Normal levels of renin in the blood is 0.29 to 3.7 mg / l. Increase in primary hypertension, malignant hypertension, renal artery disease.
The mechanism of action of angiotensin in renal directly caused by contraction renal arterioles go, thus increasing the glomerular filtration rate. This mechanism helps regulate renal blood flow. Stimulate adrenocortical aldosterone secretion, the hormone increases the absorption of sodium and water in the renal tubules. Increased water reabsorption in the kidney (due to the influence of ADH is secreted from the post-yen). Also Angiotensin also stimulates the thirst center, increases in water and the response of the central sympathetic system increases blood pressure.
2.3. Histopathological lesions renal hypertension
In the kidney, early lesions found in the blood vessels and arteries to glomerulonephritis, including arteries in the glomeruli. Basic is hyaline lesions of medial arterial wall in the glomeruli, leading to damage to the glomerular capillary coil section.
  Characterized by damage to the endothelium. Endothelial cells have room peeling off the membrane, creating the cavity is filled with the material in plasma and collagen, causing narrowing of the arteries. In addition, the medial necrosis, collapse of the glomerular capillary tufts anemia.
  The first stage of hypertension, found increased plasma flow through the kidneys, and increased hydrostatic pressure in glomerular capillaries, which appear microalbuminuria. Later stage progressive glomerular sclerosis up, reduced glomerular filtration rate and renal failure.
2.4. Progression of renal disease due to hypertension
American Society Nephrology 2012 classification of chronic kidney disease and chronic renal failure in stages as follows:
The first phase is the period of increased renal ultrafiltration, increased kidney size, characterized by increased glomerular filtration rate of 20-50% compared with the age of the patient. Increased pressure within the glomeruli become the cause kidney damage. Most of the signs outside the blood pressure has no symptoms in other organs such as the eyes, heart, kidney disease signs also appeared much later.
The next phase progresses silently with microalbuminuria normal or near normal (20μg / min), appear in 90-95% patients 1-5 years. Glomerular filtration rate is normal in most patients. When histopathological examination found relaxing capillaries and glomerular basement membrane thickening. This phase signal microalbuminuria is important in evaluating patients and treatment monitoring. Each day an adult normal excretion from 150 to 200 mg of protein in the urine. However, only 10-20 mg of protein is albumin. If the amount of albumin excretion in urine  30 mg / day, there are unusual: in the range 30-299 mg / day is called microalbuminuria amounts (microalbuminuria) and 300 mg / day or more, known as albuminuria Forest ready (overtalbuminuria). Albuminuria reflects endothelial dysfunction Body: Urinary Albumin-often seen as a marker of kidney lesions. Especially in obese patients with diabetes. There are some people with hypertension but never progressed to hypertensive renal disease. But they can have the stage of kidney damage manifested, for example, during an acute onset, or after heavy exercise after a meal rich in protein ... At this point the microalbuminuria may increase, even with proteinuria, but then returned to normal levels. Urinary albumin excretion may fluctuate as a result, so only diagnose microalbuminuria or clinical albuminuria when at least two of three urine samples were taken over a period of 3-6 months for abnormal results. This change is also one of the causes of the differences in the incidence of microalbuminuria in patients hospitalized by a study in the UK, the US is about 20%, while in Europe, with about 12 %. 19% of patients with disease duration is relatively short (1-5 years), were found to have microalbuminuria. Many researchers agree that, with hypertension, disease duration is closely related to the incidence of microalbuminuria, up to 40-50% positive disease after 30 years. Incidence is usually estimated at about 2%, this rate will be reduced if good blood pressure control. Factors related to microalbuminuria is state controlled hypertension, retinopathy, abnormal blood lipids.
Later stage, vascular relaxation phenomena and glomerular basement membrane thickness continues to increase. Glomerular filtration rate began to decline at the end of this period. Microalbuminuria may at 20-200μg / min (200-300μg / 24 hours). Hypertension is often not treated well, the numbers are usually higher blood pressure complications with other agencies.
Then the stage renal disease has manifested a clear, permanent positive proteinuria (> 0.5 g / 24 hours). This could be called the clinical stage renal disease. Hypertension is often unstable, glomerular filtration rate and rapidly declining. Hypertensive renal disease was considered inevitable progress of all people with hypertension. In fact research has shown that about 80% of people with hypertension have microalbuminuria will develop the disease if treated well, but found that approximately 30% of patients with microalbuminuria, albuminuria back to normal, 50% still remain with microalbuminuria and only 20% progress to proteinuria.

The last phase is the period of severe renal impairment. Pathological lesions characterized by the phenomenon of glomerular sclerosis. In the case of hypertensive kidney disease, glomerular filtration rate decreased in parallel with the increased level of microalbuminuria. Speed reduction dramatically different from one person to another but relatively constant in each person. Many studies show that the average rate of decline of glomerular filtration rate is 10-12ml / min / year. Blood pressure is the most important determining factor affecting the rate of decline in glomerular filtration rate. Hypertension occurs in approximately 80% - 90% of patients with chronic renal failure last stage, which often both systolic blood pressure and diastolic hypertension or isolated systolic hypertension systolic well dominant than diastolic hypertension. Hypertension is often improved after dialysis withdraw excess fluid volume. The increase in renin secretion is due to lack of access glomerular blood, but can also be caused by ataxia, increased renin production by keeping salt water. Other factors also contribute to hypertension in renal failure as dependent catecholamine nervous system, antidiuretic hormone, dysregulated prostaglandin system, the kinin, diuretic factors atrium.

Cerebral venous anatomy

The venous system of the brain is characterized by a thin vein, no muscle tissue and no van as the other veins. The blood from the veins of the brain and the brain drain into the dural sinuses and then into the jugular. The cerebral venous includes three important groups of cerebral venous shallow, deep cerebral veins and the posterior fossa vein.
1. The cerebral venous agriculture (cortical veins and sinuses along)
The cerebral venous shallow groove along the cortex is responsible for draining blood from the cerebral cortex and white matter. The vein frontal cortex, occipital peak and into the sinus along, whereas the middle cerebral venous sinus drainage into the side, the middle cerebral vein running along the slot Sylvius to drain into the sinuses and sinus butterfly top hang. Trolard sinus venous connection along with middle cerebral vein. Labbe go veins beneath the temporal lobe along the temporal occipital groove, connecting with cerebral venous sinus between the cave. The veins are the same because there is no class or the valve body so that they can relax to the direction of blood flow will be reversed if the venous sinuses become blocked.
2. The deep cerebral veins
The deep cerebral veins include the Galen vein, veins in the brain, veins background (Rosenthal), vein pattern hill (thalamostriate), vein wall (septal). The deep cerebral venous drainage of deep white matter and basal ganglia in the brain into a vein, then the veins together make up a large vein Galen and straight into the sinus.
3. The veins of the posterior fossa
The veins of the posterior fossa is divided into three main groups: the group on drainage into Galen; previous groups before draining the cerebellum, pons and the medulla; group under flow into the Social Herophile, straight sinus and transverse sinus neighborhood. Generally, the veins of this region finally ended in transverse sinus. Sinus along, sinus and transverse sinus be connected directly at the sinus drainage in the posterior fossa. Therefore, a thrombotic process areas can weaken vein draining most of the brain.
4. The meningeal veins
The meningeal veins, also known as the dural sinuses. The dural sinuses located between two layers of dura, including upper and lower longitudinal sinus, sinusitis and sinus cave caves, rocks above and below the sinus, occipital sinus, straight sinus, transverse sinus and sigmoid. The dural sinus or sinuses are inflamed rules along, and sinus cavity inside the cave.
Sinus along crested near where the venous circulation to the face and nose. This sinus runs along the rear of the dock sickle occipital cerebrum. Here, this cavity with straight sinus and the creation of the confluence Herophile. Sinus drainage along the majority of cortical blood. Due to the continuation of the bone marrow should venous sinus along the vulnerability causes infection or trauma to the face and scalp.
Along the lower sinus: located at the shore of sickle free and receive intravenous brain cortex in both hemispheres of the veins as well as the corpus callosum, poured into the cavity in the back straight.
Straight sinus: run in the grip of sickle cerebellum and brain in the tent between sinus along with the opportunity to save Herophile below, but also be able to take off by pouring directly into the left sinus. Straight sinus venous getting into Galien.
The sinus from where the jugular Herophile to two sections: horizontal section adjacent to the edge of the tent brain and sigmoid segment ran on the mastoid bone. This sinus drainage of blood from the cerebellum, brainstem and the back of the cerebral hemispheres. Due to anatomical structures such, the sinuses can be affected when mastoiditis and otitis media.
Occipital sinus following includes a vertical midline from Herophile opportunity to shore up the back of the foramen magnum and a horizontal section of the hole in each side of the occipital and connect with each bay jugular.
Save Herophile Society: the intersection of the branches to and along the sinus, straight sinus, sinus and the occipital sinus later. Its position is located in the occipital mound.
The cave is two sinus venous structures located near sphenoid. In sinus hang with some important components include the cranial nerves III, IV, VI and V2 at a party, VI nerve and the carotid artery in the sympathetic plexus located in the central part sinus. This sinus drainage of blood from the front of the eye socket and the base of the brain enters the sinus stone top and bottom to finally flow into the jugular vein.

The area's dominant veins as arterial unclear because very rich continuation of the cortical veins. It creates favorable conditions for the spread of blood clots or infections among blood vessels but on the other hand, can help to develop collateral circulation in cases of venous blockages.

Anatomy of cerebral veins and sinous

The veins of the brain have no muscular tissue in their thin walls and possess no valves as compared to other types of veins. They emerge from the brain and lie in the subarachnoid space. They pierce the arachnoid mater and the meningeal layer of the dura and drain into the cranial venous sinuses. Blood from both brain is drained by cerebral veins into dural sinuses and then into the jugular.  Cerebral veins is divided into 3 important groups which are superfical cerebral veins, deep cerebral veins and posterior fossa veins.

The drug metabolism - Pharmacokinetics

The purpose of drug metabolism
To elimination of foreign substances (drugs) out of the body. But as we know, the drug molecules are soluble in fat, not ionized, easily absorbed through the cell membrane, attached to plasma proteins and retained in the body. Want eliminated, the body must metabolize these drugs so that they become the polar compound, easily ionized, thus becoming less soluble in fat, protein attached to hard, hard absorbed into the cells, and because so, than in water soluble, easily eliminated (by the kidney, feces). Without the process of transformation, a number of very lipophilic drugs (such as pentothal) may be retained in the body for over 100 years.
Where metabolism and enzymes catalyze the metabolism
Intestinal mucosa: protease, lipase, decarboxylase
Serum: esterase
Lungs: oxydase
Enterococci: reductase, decarboxylase
Central nervous system: monoaminoxydase, decarboxylase
Hepatic metabolism is the main place, contains most of the enzymes participating in drug metabolism, will present at the following
The main metabolic reactions
A substance taken into the body will follow one path or the following:
Are absorbed and excreted unchanged dump: bromide, lithium, saccharin.
Metabolized B (Phase I), and C substances (phase II) and elimination
Metabolized D (phase II) and elimination
A substance that may or inactive, born substance B or no activity. Agent C and D is not inherently biological activity. A mother nature can generate a lot of metabolite B or C.
The response in phase I
Through this phase, in the form of the drug is soluble in fat will become more extreme, more water-soluble. But in terms of biological effects, the drug can be inactivated, or reduced activity, or sometimes increased activity, becomes active.
The key reaction in this phase include:
Oxidative reactions: very common reaction, catalyzed by the microsomal liver enzymes, especially hemoprotein, cytocrom P450.
Hydrolysis by the enzyme esterase, amidase, protease ... In addition to the liver, serum and other tissues (lung, kidney ...) also have this enzyme.
Reduction reaction.
Oxidation reactions. This is the most common reaction, catalyzed by oxidative enzymes (mixed - function oxidase enzymes System- MFO), that many of microsomal liver enzymes, especially cytochrome P 450 they (Cyt- P450), is the membrane protein containing hem (hemoprotein) localized in the smooth endoplasmic reticulum of hepatocytes and several other tissues. In the human body is seen with type 17 and type cytochrome P450 lot less participation metabolism of endogenous and exogenous substances from the environment, medicine. Oxidation reactions of this type requires NADPH and O2.
The reaction was carried out in several steps:
1) The substance (drugs, RH) reacts with oxidized form of Cyt P 450 (Fe 3+) complexes formed Rh-
P450 (Fe 3+)
2) Rh- P450 complex (Fe 3+) received one electron from NADPH, reduced to RH - P450 (Fe2 +)
3) Then, complex Rh- P450 (Fe2 +) react with oxygen molecules 1 and 2 electrons from NADPH 1
to form reactive oxygen compound.
4) Finally, one oxygen atom is released, creating H 2O. 2 oxygen atoms also be oxidized
substrate (medicine): RH  ROH, and Cyt.P450 be reconstructed.
Reduction reaction. Reduction of nitro derivatives, aldehydes, carbonyl by the enzyme nitroreductase, azoreductase, dehydrogenase ...
Hydrolysis reaction. The ramp ester and amide hydrolysis by the enzyme being esterase, amidase in plasma, liver, and other tissues of the gut.
The response in phase II
The material passing through this phase of the complex problem becomes no longer active, easily soluble in water and is excreted. However, in this phase, sulfanilamid was acetylated to become soluble in water, forming crystals in the kidney tubules, causing hematuria or anuria.
These reactions are in phase II conjugation reactions: an endogenous molecule (glucuronic acid, glutathione, sulfate, glycine, acetyl) will pair with a group of drugs chemically to form strong complexes soluble in water . Typically, the response in Phase I will create the necessary components for functional group reactions in phase II, which is the group - OH, -COOH, -NH2, -SH ...
The main reactions: reactions associated with glucuronic acid, sulfuric acid, amino acids (mainly glycine), respond acetylation, methylation. These reactions require energy and endogenous substrates, which are characteristic of phase II.
In addition, there are a number of drugs metabolized completely, which is highly polar compounds (such as acid, strong base), non permeable layer of microsomal fat. Much is eliminated as quickly as hexamethonium, methotrexate.
Some non-polar substance can not be transformed: barbital, ether, halothane, dieldrin.
A drug may be metabolism reactions occur simultaneously or sequentially. Examples of paracetamol and sulfo- glucuro- the same time; chlorpromazine metabolized in the human phenothiazines over reaction, then the branch is also through a series of reactions to last for more than 30 different metabolites.
Factors that alter drug metabolism speeds
age
Infants lack of drug metabolizing enzymes.
Elderly people and aging enzymes.
hereditary
Do enzymes appear atypical approximately 1: 3000 people have atypical cholinesterase, very slow hydrolysis of suxamethonium to prolong the effects of this drug.
Isoniazid (INH) was eroded by acetylation. In one study, oral 10 mg / kg isoniazid, after 6 hours of isoniazid in the amount of blood found in a group is 3-6 g / mL, in the other group just 2,5g / mL. The first group is the group of slow acetylation, easy-toxic dose reductions due to the CNS. Genetics, slow acetylation group, found 60% were white, 40% black and 20% are yellow. Group after group acetylation is fast, need to increase the dose, but acetyl isoniazid metabolites toxic to the liver.
The lack of glucose 6 phosphate dehydrogenase (G6PD) is prone to haemolytic anemia when used Phenacetin, aspirin, quinacrin, some sulphonamides ...
Externalities
Substance-induced metabolic enzymes: effects increases in microsomal liver enzymes students, increase the activity of this enzyme.
For example, phenobarbital, meprobamat, clorpromazin, phenylbutazone, and hundreds of other drugs: the use of these drugs with drugs metabolized by the enzymes were induced to reduce the effects of the drug combination, or by itself (ng out tuo habituation).
In contrast, with the new drug must pass metabolism becomes active ("prodrug"), when used in conjunction with drug-induced toxicity will be increased (parathion  paraoxon)
Metabolic enzyme inhibitors: a number of other drugs such as chloramphenicol, d icumarol, isoniazid, quinine, cimetidine ... has the effect of inhibiting, reducing the activity of drug metabolizing enzymes, thereby increasing the effectiveness of medications coordinated.
Factors pathologic
The disease liver damage department officials will degrade students collect snails of liver metabolism: hepatitis, fatty liver, cirrhosis, liver cancer ... easily increase the effects or toxicity hepatic metabolism as tolbutamid, diazepam.

The disease reduces blood flow to the liver, such as heart failure, or β blockers prolong sympathetic system will reduce the number of liver extracts, which lasted t / 2 of the drug has a high coefficient of extraction in the liver as lidocaine, propranolol, verapamil, isoniazid.

Absorption of drugs - Pharmacokinetics

Absorption is the transport of drugs from the drug (oral, injection) into the bloodstream and then throughout the body, to which effect. Thus the absorption will depend on:
- Solubility of drugs. Drugs used in the form of an aqueous solution more readily absorbable form of oil, suspension or rigid.
- PH for absorption in place that affect the ionization and solubility of drugs.
- The concentration of the drug. Concentrations as high as rapidly absorbed.
- Circulation in the absorption: the more circuits, more rapidly absorbed.
- The area of the absorption. The lungs, intestinal mucosa large area, quickly absorbed.
Since the factors that showed the road taken the medication will have a great impact on the uptake.
Except intravenously, in the process of absorption into the circulation, part of the drug will be destroyed by the digestive enzymes, cells of the intestine, especially in the liver, which has an affinity for drugs . Part drugs were destroyed prior to the cycle called "first pass metabolism" (absorbed or metabolized by hepatic metabolism is often the first time since taking). The new section is circulated to promote pharmacological effects, called bioavailability (bioavailability) of drugs.
Following points through the usual route of administration à v characteristics of them.
Drug absorption from the gastrointestinal tract
The advantage is easy to use because of the natural sugar absorption.
The downside is that the digestive enzymes are destroyed or drug complexes with slow food absorption. Sometimes drugs stimulate gastrointestinal mucosa, causing ulcers
Absorbed through the oral mucosa: sublingual drug
Do drugs directly into circulation should not be destroyed gastric, hepatic metabolism is not the first time
drug
The drug will pass through the stomach and intestine with the following characteristics: thick ODA:
- There pH = 1- 3 should only absorb weak acid, less ionized, such as aspirin, phenylbutazone, barbiturates.
- Generally less mucosal absorption for less vascular, contains more cholesterol, while no longer the drug in the stomach.
- When hungry absorbed faster, but excitable * In the small intestine:
Where the absorption is mainly due to the absorption of very large area (> 40 m 2), the perfused much, pH increases to base (pH 6 to 8).
- Are less ionized but if little or no lipid soluble (Sulfaguanidine, streptomycin) is less absorbed.
- The drug carries amine 4 will be difficult to absorb strongly ionized, for example the type of Cura.
- The sulfate anion SO4- - unabsorbed: MgSO4, Na2SO4 only effective bleaching.
Rectal suppository
When not be administered orally (by vomiting, coma caused by, or in children) then put on medication labor ng anus. Digestive enzymes are not destroyed, about 50% of drug absorbed from the rectum will pass hepatic metabolism original subject.
The downside is not completely absorbed and can irritate the lining of the anus.
injections
- Subcutaneous injection: because many sensory nerve fibers to pain, less blood vessels to slow the absorption of drugs
- Intramuscular: to overcome the above disadvantages of two subcutaneous injections - some drugs can cause muscle necrosis as Ouabain, calcium chloride shall not be administered intramuscularly.
Intravenous injection: the drug is rapidly absorbed, completely, can be quickly adjusted dose. Use of aqueous injection or intramuscular irritating not to be less sensitive for intravascular blood dilution and injection drug faster if slow.
Soluble drugs, drug precipitate of blood components h ay dissolving drugs are not injected red blood vessels.
Topical
- Absorbed through the mucosa: drugs may apply, drip into the nasal mucosa, throat, vagina, bladder to the treatment site. Sometimes, due to rapid absorption, directly into the blood, do not be evil c enzymes destroyed in the process of absorption should still have systemic effects: ADH nasal inhalation powder; anesthetics (lidocaine, cocaine) applied topically, can be absorbed, causing systemic toxicity.
- Dermal: less drug can be absorbed through intact skin. The topical (ointment, youth c massage, plaster) agricultural work site antiseptic, antifungal, analgesic.
However, when skin lesions, infections, burns ... drug can be absorbed. Some fat-soluble toxins can be absorbed through the skin causing systemic toxicity (organophosphate pesticides, toxic industrial aniline).
Moisturizing ointment place (bandage), massage, use vasodilators in place, using the method of ion -
di (Iontophoresis) drugs are absorbed through the skin increases.
There are new forms of medication patches, releases the drug slowly and steadily over the skin, maintaining a stable dose reachable enough blood: scopolamin patches, estrogen, nitrites.
Caucasian infants and young children, with thin stratum corneum, permeability strong, easily irritated, so be cautious when using the restricted area of the ointment.
- Eye drops: mostly weights i work place. When drugs flowing through the tube tip - down rules for the nasal mucosa, the drug can be absorbed directly into the bloodstream, causing unwanted effects.
The other way
- Through lung gases and vaporized medicine can be absorbed through the alveolar epithelial cells, airway mucosa. Since a large area (80-100 m2) should be rapidly absorbed. This is the way the absorption and elimination of anesthetic vapor. The absorption depends on the concentration of anesthetic in the air inhaled, respiratory ventilation, the solubility of anesthetics in blood.
Some drugs can be used as a spray for topical treatment (asthma).
- Inject the spinal cord: usually injected into the subarachnoid space or epidural to numb the lower
(lower extremities, pelvis) with high density solution (hyperbaric solution) than CSF.
Pharmacokinetic parameters of absorption: bioavailability (F)
define
The bioavailability F (bioavailability) is the percentage of drugs in circulation was also active as the velocity and absorption (Cmax and Tmax expressed through) than the dose used. The bioavailability reflects absorption.
meaning
- When changing the excipients, the apothecary will change the solubility of the drug (active ingredient) and change of medication F. Thus, two types of cells ch ế same product can have two different bioavailability. The concept of bioequivalence (bioequivalence) used to compare the F of different dosage forms of the active ingredient 1: F1 / F2.
- When changing the chemical structure, can make changes F: Ampicillin with F = 50%
Amoxicillin (attach additional OH group) with F = 95%.
- The hepatic drug metabolism as the first, or transformed into circulation before (first pass metabolism) reduces the bioavailability of the drug. But sometimes because of the drug through the liver to be metabolized to active though oral bioavailability is low but the pharmacological effects are not bad intravenous injection. For example propranolol have oral bioavailability is 30% but it is metabolized in the liver to 4 - OH still active as propranolol propranolol.
- The F factor altering drug user:
Dietary changes the pH or gastrointestinal motility. . Age (children, elderly): change of the enzyme activity. . Medical conditions: constipation, diarrhea, liver failure.
Drug interactions: two drugs may dispute in which the absorption or alter the solubility, the separation of each other.

The drug delivery - Pharmacokinetics

After being absorbed into the blood, part of the drug binds to plasma protein (the protein in cells is also associated drug), the drug free is not attached to the protein through a circuit to turn on the model, in which effect (the receptor), on reserve size, or metabolized and excreted. Between free drug concentration (T) and protein complexes - medication (P-T) always have a dynamic balance:
T + P  P - T
The process of drug delivery depends on the circulation area. Depending on the vasculature, thuongchia body into 3 time (H2)

Two types of factors that affect the distribution of drugs in the body:
On the side of the body: the nature of the membrane, the membrane capillaries, the number of binding sites and pHcua environmental medicine.
Towards drugs: molecular weight ratio of lipid and water soluble, acidic or base, of ionization, the affinity of the drug to the receptor.
The drugs linked to plasma proteins
Location attached
Much attached to plasma albumin (the drug is weak acid) and vaoglycoprotein (the drug is weak base) by binding reversibly.
Binding
Depending on the affinity of each drug to plasma proteins (Table 1)

The drugs linked to plasma proteins depends on three factors:
The number of drug binding sites on plasma proteins.
Molar concentrations of the drug-binding proteins.
Constant associated drug or drug affinity constants.
Meaning of drug binding to plasma proteins
How easily absorbed, slow elimination for high blood protein absorption in place, the drug will be pulled quickly to the circuit.
Plasma protein stroma, the drug stockpile, after applying the drug, the drug will be released from the free-form and form new freedom through biological membranes to exert pharmacological effects.
Free drug concentration in plasma and interstitial fluid outside always in equilibrium. When the drug concentration in interstitial fluid reduction in plasma drug will come out, will release the drug binding protein drugs to keep the balance.
Many drugs can be attached to the first position of the plasma proteins, causing the dispute, depending on the affinity of the drug. Drugs were ejected from the protein will increase the effect, can be toxic. For example, on the tolbutamid used to treat diabetes, joint pain now, sharepoint phenylbutazone, phenylbutazone will push tolbutamid a free-form, causing sudden hypoglycemia.
Sometimes both endogenous drug pushing, causing poisoning endogenous: salicylates push bilirubin, sulfamid insulin hypoglycemia push out of position associated with protein.
During treatment, the initial loading dose to saturate the binding site, then the maintenance dose to steady work.
In the case of pathological increase - decrease plasma proteins (such as malnutrition, liver cirrhosis, renal failure, elderly ...), required dose adjustment.
The redistribution
Common to many of the fat soluble drug, which acts on the central nervous and intravenous drug use. One typical example of this phenomenon is anesthetized with thiopental, a fat-soluble drugs. So much brain perfusion, the drug concentration in the brain achieve maximum very quickly. When stopped injection, plasma concentrations of thiopental in rapid decline since the drug diffuses into the tissues, especially adipose tissue. Drug concentrations in the brain decreases with it ng plasma. So rapid induction, but the effects are not long passion. As for the additional dose to maintain anesthesia, drugs accumulate in fatty tissues. Since this drug is released into the blood to the brain when the drug was stopped, making drug effects setups become prolonged.
The special distribution
Transporting drugs into the CNS
Mode of transportation: the drug must pass 3 "fence":
From brain capillaries in nervous tissue (the blood - brain): soluble drug in the lipid permeable, water-soluble drugs are difficult to overcome because of glial cells (astrocytes - astrocytes) is very close together, at the basement membrane, in addition to the capillary endothelium.
From the choroid plexus in the cerebrospinal fluid (BBB - meningitis or reduced blood-CSF) as fence on; strong lipid soluble drug.
From CSF in neural tissue (CSF barrier - the brain), performed by passive diffusion.
The determinants of the speed transport drugs into the cerebrospinal fluid and brain are the same principles permeate biological membranes, such as:
The level of drug linked to plasma proteins.
The degree of ionization of the free drug (depending on pH and pKa).
Distribution coefficient lipid / water free of the drug is not ionized (solubility in lipids).
Drugs from the CSF is done m ot part by active transport mechanisms in the choroid plexus (an active transport system for the weak acid and a different system for the weak base). From the brain, the drug diffusion mechanism passive, dependent mainly on the lipid solubility of the drug.
The blood - brain depends on the age and disease status: in infants and young children, less the amount of myelin structure "fence" is not enough "tight" so easy diffusion drugs in the brain. Penicillin failed the normal meninges, but blocks inflammation, penicillin and other drugs can pass.
BBB nature of a lipid barrier without pipes, so, for the strong of lipid soluble substances, as there is no fence. Some small areas of the brain such as the human side of the hypothalamus, periventricular floor 4, pineal and pituitary lobe after no fence.
As a result of shipping:
The drug can dissolve in fat absorbed very quickly into the brain, but it does not stay long (see "redistribution").
Ionized many drugs, soluble in fat, hard to penetrate into the central nervous: atropine sulfate, bearing amine 3, less ionized, enter the CNS; atropine methyl bromide also bring amine 4, strongly ionized, not to be CNS.
You can change the drug distribution between plasma and brain by changing the pH of the plasma: In the treatment of phenobarbital poisoning, transmission of NaHCO 3 to raise blood pH (7.6) beyond the pH of the cerebrospinal fluid (7.3), making the concentration of ionized plasma concentration of phenobarbital increases nonionic will take the form of reduced non-ionized drugs from CSF
in blood.
Transporting drugs across the placenta
method
Fetal capillaries in the villi are embedded in the mother's blood pool, so blood between mother and fetus "placenta". The permeability of capillaries m antenna increases with gestational age fetus. The absorption and also according to the general rule:
The fat-soluble drugs passive diffusion: anesthetic vapor, (protoxyd nitrogen, halothane, cyclopropan), thiopental.
Active transport: amino acids, ions Ca ++, Mg ++.
Competent cells (pinocytosis) with drops of maternal plasma.
result
Except for the water-soluble drugs have molecular weights larger than 1000 (such as dextran) and the primary amine 4 (galanin, Neostigmine) did not pass the placenta, many drugs can enter the fetal blood, dangerous for pregnant (phenobarbital, sulphonamides, morphine), therefore, should not be taken as "placenta".
The amount of protein- bound drugs in maternal blood plasma drug concentration is high, low free, drug free only new blood to be human, in this part of the drug to attach to human blood plasma proteins, so the concentration free drug in the blood lower. To obtain free drug concentrations similar to maternal blood, need some time to 40 minutes. For example, injection of thiopental to the mother during labor, and after 10 minutes, the mother is blood concentrations of thiopental in children has not achieved the maze, which explains why the mother was sleeping but can lay out child I was still awake.
In addition, the placenta has many as cholinesterase enzyme, monoamine oxidase, hydroxylase may metabolize the drug, to reduce the effect to protect the fetus.
The cumulative drug
Some drugs or poisons have very tight linkage (usually covalent link) with a number of tissues in the body and is retained for a long time, tens monthly nă m after dosing, with the only is 1: DDT linked to fatty tissue, tetracycline attached to bone, tooth germ, As keratinocytes attached to ...
Some drug accumulation in skeletal muscle cells and other tissues with higher concentrations in the blood. If the binding is reversible drug, the drug will be liberated from the "reserves" in the blood (see "redistribution"). Quinacrin concentrations in liver cells when used long-term drug may be higher plasma concentrations several hundred times due to liver cells with active transport processes quinacrin pulled into cells.
Pharmacokinetic parameters of the distribution: the volume of distribution (Vd)
define
The volume of distribution indicates an apparent volume (no really) contains all the medicine has been taken into the body to the concentration of the drug concentration in the same command ết.
Vd = (D / Cp) lit
D: dose of medication into the body (mg) intravenously. If another way to take into account the bioavailability: D x F
Cp: plasma concentrations measured immediately after delivery and before elimination. Eg, there is no real volume, measured by L (liter) or L / kg.
For example, a person weighing 60 kg, there may be water in 36 L (60% of body weight), was taking 0.5 mg (500 g) with F oral digoxin is 0.7. Measurement of plasma digoxin concentrations found Cp = 0.7 ng / mL (0.0007 mg / mL).
So: Vd = (0.5 x 0.7) / 0.0007 = 500L or 8.3 L / kg
Vd = 500L, grew by nearly 14 times the amount of water in the body so that the apparent volume.
Reviews and clinical significance
Vd is the smallest in plasma volume (3L or 0,04L / kg). There is no limit on the Vd. Ie the greater the drug proved much more attached to the model: the treatment of bone and joint infections should choose appropriate antibiotics have large Vd.
Knowing eg drug, calculate the dose needed to achieve hats g desired plasma:

D = Vd x Cp